Harvey Robert Klingensmith is Director of CORE LABORATORIES N V. Currently has a direct ownership of 26,226 shares of CLB, which is worth approximately $495,671. The most recent transaction as insider was on Apr 01, 2023, when has been sold 5,485 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.2K
0% 3M change
0% 12M change
Total Value Held $495,671

Harvey Robert Klingensmith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2023
BUY
Exercise of conversion of derivative security
-
5,485 Added 17.3%
26,226 Common Shares
Apr 01 2022
BUY
Exercise of conversion of derivative security
-
4,307 Added 17.19%
20,741 Common Shares
Apr 01 2021
SELL
Payment of exercise price or tax liability
$2,197 $30.1 p/Share
73 Reduced 0.44%
16,434 Common Shares
Apr 01 2021
BUY
Exercise of conversion of derivative security
-
14,507 Added 46.78%
16,507 Common Shares

Also insider at

CLB
Core Laboratories Inc. /DE/
HRK

Harvey Robert Klingensmith

Director
Houston, TX

Track Institutional and Insider Activities on CLB

Follow CORE LABORATORIES N V and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLB shares.

Notify only if

Insider Trading

Get notified when an Core Laboratories N V insider buys or sells CLB shares.

Notify only if

News

Receive news related to CORE LABORATORIES N V

Track Activities on CLB